Stocktoria
CRESCENT BIOPHARMA, INC. CBIO
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2014-01-10
CRESCENT BIOPHARMA, INC. insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Lynch Ryan | See Remarks | 2026-06-22 | Sell | 465 | $17.99 |
| Pinkas Jan | Chief Scientific Officer | 2026-06-22 | Sell | 1,288 | $17.99 |
| Scalzo Richard William | Chief Financial Officer | 2026-06-22 | Sell | 1,112 | $17.99 |
| Bispham Barbara Harlin | See Remarks | 2026-06-22 | Sell | 1,218 | $17.99 |
| Im Ellie Eunkyung | Chief Medical Officer | 2026-06-22 | Sell | 1,219 | $17.99 |
| McNeill Jonathan | President and COO | 2026-06-22 | Sell | 20,549 | $17.99 |
| Brumm Joshua T | Chief Executive Officer | 2026-06-22 | Sell | 42,305 | $17.99 |
Source: SEC EDGAR filings · CIK 0001253689 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.